Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison

The efficacy of a hydrogel spacer in stereotactic body radiotherapy (SBRT) has not been clarified. We evaluated the safety and efficacy of SBRT in combination with a hydrogel spacer for prostate cancer.

Source: Radiation Oncology - June 12, 2021 Category: Cancer & Oncology Authors: Mami Ogita, Hideomi Yamashita, Yuki Nozawa, Sho Ozaki, Subaru Sawayanagi, Takeshi Ohta and Keiichi Nakagawa Tags: Research Source Type: research